Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
暂无分享,去创建一个
P. Harrigan | B. Yip | R. Hogg | J. Montaner | E. Phillips | V. Lima | A. Hayden | S. Gutiérrez | N. Jahnke
[1] F. Raffi,et al. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity. , 2008, AIDS.
[2] P. Harrigan,et al. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients , 2007, AIDS.
[3] J. Brooks,et al. Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda , 2007, Journal of acquired immune deficiency syndromes.
[4] H. Yazaki,et al. HLA-Cw8 primarily associated with hypersensitivity to nevirapine. , 2007, AIDS.